Biotech

All Articles

Former Seagen CEO unveils brand new start-up Ottimo Pharma

.After antibody-drug conjugate (ADC) professional Seagen was offered to Pfizer last year for a monst...

Ironwood produces more purpose $1B GI medicine with brand new subgroup data

.On the heels of a period 3 gain that fell short to impress investors, Ironwood Pharmaceuticals is a...

Novartis inks $150M package for autoimmune molecular adhesive

.Do not cease Monte Rosa Therapies currently. The Boston-based biotech is having a ball after signin...

Jade takes officer team along with Chinook vets-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of substantial leadership hirings, shooting...

Septerna goes public with upsized offering of $288M

.Celebrating his business's upsized initial public offering (IPO), Septerna chief executive officer ...

AbbVie creates Richter wealthier, paying out $25M to make up finding contract

.AbbVie has gone back to the resource of its antipsychotic giant Vraylar trying to find another hit,...

GenSight enters final weeks of cash money path as income stream edges out of grasp

.GenSight Biologics is actually weeks far from lacking money. Again. The biotech simply possesses en...

AZ licenses disposed of rare illness drug to Monopar Therapies

.Monopar Rehabs is recouping a drug coming from the scrap heap of AstraZeneca's uncommon disease pip...

Arcus' brand-new HIF-2a information in kidney cancer cells mention prospective edge over Merck's Welireg, experts mention

.Along with brand-new records out on Arcus Biosciences' speculative HIF-2a prevention, one team of p...

Roche bets around $1B to expand Dyno gene therapy shipping pact

.After creating a gene treatment alliance along with Dyno Therapies in 2020, Roche is back for even ...